期刊文献+

早产儿呼吸道分泌物解脲脲原体阳性与新生儿肺损伤的关系 被引量:4

Analysis of the Relationship between Premature Respiratory Secretions of Ureaplasma Urea Original Body and Neonatal Lung Injury
下载PDF
导出
摘要 【目的】探讨早产儿呼吸道分泌物解脲脲原体(Uu)阳性与新生儿肺损伤的关系。【方法】选择2014年1月至2015年8月本院新生儿重症监护病房(NICU)收治的246例以呼吸道症状入院的早产儿作为研究对象,详细记录每位患儿的临床资料,入院时取胃、咽部或气道分泌物,采用荧光定量聚合酶链反应法检测Uu核酸,根据检测结果分为阳性组和阴性组;比较两组患儿的基本临床特点,感染标志物,新生儿呼吸窘迫综合征(RDS)、先天性肺炎、支气管肺发育不良(BPD)发生率及住院天数。【结果】246例早产儿中,Uu结果阳性59例,阴性187例。Uu阳性组新生儿RDS发生率显著低于阴性组;先天性肺炎、BPD发生率显著高于阴性组,差异均有统计学意义(P〈0.05)。【结论】呼吸道分泌物Uu阳性增加了早产儿先天性肺炎、BPD的发生几率,相反,其可促进胎肺的成熟,是新生儿RDS的保护性因素。 [Objective]To research the relationship between premature respiratory secretions of ureaplasma urea original body and neonatal lung injury.[Method] A total of 246 cases of premature infants with respiratory symptoms in the neonatal in tensive care unit in the Maternal and Child Health Hospital of Hunan Province from January 2014 to August 2015 were selected as the research object. The clinical data of each child was recorded in detail. According to the test results of fluorescent quami tative PCR detection of Uu nucleic acid with stomach and, pharyngeal airway secretions which were taken wheit ehey were admitted to this hospital, the patients were categorized into a positive group and a negative group. Basic clinical characteristics, infection markers, neonatal respiratory distress syndrome (RDS), congenital pneumonia, and the incidence of bronchial pulmonary dysplasia (BPD) and the length of hospital stay of the two groups were compared.[Result] In the 246 cases of premature infants, 59 cases of Uu were positive and 187 cases of Uu were negative. In the Uu positive group, incidence of neonatal respiratory distress syndrome was 32.2% (19/59), while in the negative group, it was 45.5% (85/187). Incidence of congenital pneumonia in the Uu positive group was 35.6% (21/59), while incidence in the negative group was 21.9% (46/187). After more than 28 days in the hospital, the incidence of bronchial pulmonary dysplasia in the Uu positive group was 16.9% (10/ 59), while incidence in the negative group was 8.02 % (15/187). The length of hospitalization in the Uu positive group was obviously longer than in the Uu negative groups; the difference had statistical significance.[Conclusions] For preterm infants, Uu positivity in respiratory secretions increased the incidence of congenital pneumonia and bronchial pulmonary dysplasia, which extended the length of hospital stay. So, it is a protective factor of neonatal respiratory distress syndrome.
出处 《医学临床研究》 CAS 2016年第12期2329-2331,共3页 Journal of Clinical Research
关键词 婴儿 早产 解脲支原体 呼吸窘迫综合征 新生儿 支气管肺发育不良 Infant, Premature Ureaplasma urealyticum Respiratory Distress Syndrome, Newborn Bronchopulmonary Dysplasia
  • 相关文献

参考文献2

二级参考文献37

  • 1Doyle LW, Ehrenkranz RA, Halliday HL. Dexamethasone treatment after the first week of life for bronehopulmonary dysplasia in preterm infants: a systematic review. Neonatology, 2010, 98:289-296.
  • 2Tin W, Wiswell TE. Drug therapies in brunchopulmonary dysplasia: debunking the myths. Semin Fetal Neonatal Med, 2009, 14:383-390.
  • 3Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysphasia. N Engl J Med, 1967, 276:357-368.
  • 4Lavoie PM,Dube MP. Genetics of bronchopulmonary dysplasia in the age of genomics. Curr Opin Pediatr, 2010, 22:134-138.
  • 5Bhandari A,Bhandari V. Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics, 2009, 123:1562-1573.
  • 6Merritt TA, Deming DD, Boynton BR. The 'new' bronchopulmonary dysplasia: challenges and commentary. Semin Fetal Neonatal Med, 2009, 14:345-357.
  • 7Bry K,Hogmalm A, Backstrom E. Mechanisms of inflammatory lung injury in the neonate: lessons from a transgenic mouse model of bronehopulmonary dysplasia. Semin Perinatol, 2010, 34:211-221.
  • 8Hayes D Jr,Feola DJ, Murphy BS, et al. Pathogenesis of bronchopulmonary dysplasia. Respiration, 2010, 79:425-436.
  • 9Speer CP. Chorioamnionitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia. Neonatology, 2009, 95:353-361.
  • 10Watterberg KL, American Academy of Pediatrics, Committee on Fetus and Newborn. Policy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia. Pediatrics, 2010, 126:800-808.

共引文献57

同被引文献36

引证文献4

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部